Reperfusion therapy fails to improve limb ischemia in clinical trial

07/30/2013 | TCTMD.com

The use of controlled reperfusion techniques for patients undergoing surgical revascularization did not improve their recovery from critical limb ischemia in a randomized study of 174 patients conducted in Germany. The study showed that the rates of amputation-free survival after four weeks and one year remained the same between the controlled reperfusion group and those who just had surgery.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ